Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The insular cortex is a distinct lobe of the cerebral cortex situated deep in the lateral sulcus. It is involved in integrating sensory, affective, and cognitive information, supporting processes such as interoception, emotional awareness, cognitive control, empathy, and homeostatic regulation[1][3][5][6]. The insula can be divided into anterior and posterior regions, each with specific functional roles, and is notable for its heterogeneous cytoarchitecture and complex connectivity with other brain regions[1][2][6]. Dysfunction or damage to the insular cortex is associated with a variety of neuropsychiatric and neurological disorders, including affective disorders, pain syndromes, and epilepsy[3][6][7]. The insular cortex is a brain region, not a molecule or receptor. It cannot be targeted in the same sense as typical drug targets (e.g., proteins, receptors). Any therapeutic approaches would involve modulating its activity indirectly (for example, via CNS drugs, neurostimulation, or behavioral therapies), but molecular targeting terms such as interacting drugs and mechanisms of action do not apply[3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Insular cortex.